Back to the feed
In brief
On 12.08.2026, a person holding the function "Executive member of the board of directors / senior management" at Newron Pharmaceuticals S.p.A. disclosed a purchase worth CHF 23’613 to SIX Exchange Regulation.
By amount, this ranks #2 of 2 management purchases disclosed at Newron Pharmaceuticals S.p.A. over the previous 12 months.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open
Disclosure detail
A executive member of the board of directors / senior management of Newron Pharmaceuticals S.p.A. declared a "Purchase" transaction on 12.08.2026.
SIX publishes the manager's function, never their name: no individual is named in management transactions.
Transaction date12.08.2026
Issuing companyNewron Pharmaceuticals S.p.A.
ISINIT0004147952
Transaction sidePurchase
Management functionExecutive member of the board of directors / senior management
Security typeRegistered shares
Quantity2’000
Unit priceCHF 11.81
AmountCHF 23’613
ExchangeXSWX
Notification IDT1Q8C00022
Other Newron Pharmaceuticals S.p.A. insider transactions
- Purchase · Executive member of the board of directors / senior management08.10.2026CHF 10’781
- Purchase · Executive member of the board of directors / senior management11.08.2026CHF 23’962
- Sale · Non-executive member of the board of directors02.12.2025CHF 104’218
- Sale · Non-executive member of the board of directors26.11.2025CHF 247’984
- Purchase · Non-executive member of the board of directors23.04.2025CHF 5’472
These figures aggregate public disclosures. They are not investment advice.